May Flower India
| Business category 1 | HIPS |
| City ( of main office ) | Ahmadābād, IN, India |
| Address | 83, G. I. D. C. Estate, Phase II, Vatva, |
| Phones | 91-079-25830139 |
| Fax | 91-079-25830638 |
| About | About Us We are a trusted and well established pharmaceutical company providing unmatched quality medicines in numerous compositions. Established in the year 2001 and growing into prominence within a short span of time, today, we hold a leading position in the discovery and development of drugs based upon international quality standards. We all, at Mayflower India, strive to provide the best quality products to our customers and keep ourselves engaged in continuous research to innovate new life saving drugs which are more effective and highly affordable. Due to our expertise and quality consciousness, our products are highly acclaimed not only in the country but also abroad. Having specialization in Psychotropic Medicines, we are a highly reputed manufacturer, supplier and exporter of a massive range of quality tested Medicines such as Psychotropic Medicines, Neuroleptics, Antiparkinsonian Medicines, Antidepressants, Anxiolytics and Hypnotic, Antiepileptics and Mood Stabilizers, Nootropic, Central Analgesic, GI Adjuncts, etc. In the production of all these formulations, we maintain international quality standards and perform stringent quality tests under the supervision of highly qualified team of medicos. As a result, our medicines provide guaranteed results with assured safety and speedy relief. After leading the domestic market, we are now concentrating upon expanding our international market base and be a global leader in our field. Our Product Range At Mayflower India, our team of experts performs an extensive research in developing a massive range of medicines which are of premium quality and provide an effective and assured result. Besides specializing in Psychotropic Medicines, we are the manufacturer, supplier and exporter of the following range of products Psychotropic Medicines Neuroleptics: Ojoy, Risen, Risen T, Risen Plus or Forte, Dolsi, Maricalm H, Maricalm T, Maricalm Plus, Maricalm Forte, Elzin, Trankvil T, Trankvil Plus, etc. Antiparkinsonian: Hexiflor Antidepressants: Imitab, Imitab C, Imitab Plus, Imitab Forte, Mytrip, Mytrip Plus, Mytrip H, Flunam, Do Pin, Clopram, Serly, Escer, etc. Anxiolytics and Hypnotic: Prizm, Prizm Plus or Forte, Miraz, Zepox, Zepox T, Omni, Soza Antiepileptics and Mood Stabilizers: Savy CR, Klon, Litman, Litman SR-400, etc. Nootropic: Noocet Central Analgesic: Analtra DT, Analtra P, etc. GI Adjuncts: Floritex, Floritex D, Pantakul 40, etc. Our Quality Quality has always been the first and foremost relief at Mayflower India and for us, it is the touchstone of success. Our mission is to develop high quality and innovative products for the benefit of both patients and physicians. At our company, we are committed to develop life saving medicines which can also improve the quality of life for the patients suffering from chronic illness. To ensure that all the products we manufacture can meet, if not exceed, the expectation level of our customers, we maintain a well defined quality management policy. All the products are thoroughly tested at our quality testing lab and international quality standard is maintained with each of them. Thus, we have created a long standing tradition of building relationships based on the highest standards, with our clients and cater to their needs with the best products in the industry. Our Infrastructure In its journey embarked with prominence and success, Mayflower India has established a robust infrastructural base upon which it has been growing at a rapid pace spreading its wings to various parts of the globe. This robust base, comprising of world class facilities for production, testing and R and D, empower us to manufacture flawless products and serve our clients with enhanced product quality and services. In addition, we are fortunate enough to be equipped with a dedicated and highly skilled workforce making us a forerunner in the industry. |
| Date | 2011 Oct 29, 09:10 |